BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30
• 31

• Ophthalmic Drugs Market Size, Share And Industry Analysis By Drug Type, By Dosage, By Prescription Type, By Distribution Channel, By Drug Variation, and By Region Forecast To 2028

  The global pharma & healthcare market report points out the key trends and developments taking place in this business space in the ongoing COVID-19 times.

  December 30, 2021

   · 

  7 min read
• Biotech Beach

  Leonhardt Ventures Files Patent for Bioelectric Diabetes Reversal Treatment via FABp4 Regulation and Klotho Regulation

  Leonhardt Ventures LLC announced today filing of a patent application covering bioelectric controlled down regulation of FABp4 and up regulation of klotho for the potential purpose of reversing type 1 and 2 diabetes.

  December 30, 2021

   · 

  6 min read
• Zafirlukast Market Size, Share, Growth & Industry Analysis by 2021-2028

  The global pharma & healthcare market report points out the key trends and developments taking place in this business space in the ongoing COVID-19 times.

  December 30, 2021

   · 

  7 min read
• Policy

  Mesoblast Provides Update Following Meeting With FDA’s OTAT on Remestemcel-L for Children With Acute Graft Versus Host Disease

  Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided a regulatory update on remestemcel-L for steroid-refractory acute graft versus host disease in children following its recent meeting with the FDA’s OTAT.

  December 30, 2021

   · 

  7 min read
• Business

  MedMira Reports First Quarter Results FY2022

  MedMira Inc., reported on its financial results for the quarter ended October 31, 2021.

  December 30, 2021

   · 

  3 min read